6th CEN Conference

Session

IS1: Past and Future of Bayesian Biostatistics

19 May 2026, 10:45

Room 1 A

Conveners

IS1: Past and Future of Bayesian Biostatistics

• Reinhard Vonthein (Universität zu Lübeck)

49. Bayesian Highs and Lows: A Pharma Industry Perspective

Simon Wandel (Novartis Pharma AG)

19/05/2026, 10:45

invited lecture

The pharmaceutical industry has a long history with Bayesian statistics. Already in 1986, Racine, Grieve, Flühler and Smith wrote an article entitled Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry[1], highlighting four typical applications they encountered at that time. Since then, Bayesian methods have been applied to many more problems in the pharmaceutical...

60. Bayesian approaches in time of ML and AI

Katja Ickstadt (Department of Statistics, TU Dortmund University)

19/05/2026, 11:15

oral presentation

The Bayesian approach in general has a lot to offer in times of Machine Learning (ML) and Artificial Intelligence (AI). The Bayesian framework itself offers a learning environment, where the prior, and, subsequently the posterior distributions can be updated sequentially, and where human expertise can be incorporated. The approach allows for uncertainty quantification of all quantities of...

53. Lessons learned in the last 25 years

Gerhard Nehmiz (Consultant to Boehringer Ingelheim Pharma GmbH&Co. KG)

19/05/2026, 11:35

oral presentation

Lessons learned in the last 25 years

Gerhard Nehmiz, consultant for Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany

gerhard.nehmiz.ext@boehringer-ingelheim.com

The Working Group "Bayes methods" of the IBS / German Region was founded in 2001, and met a need. It had two roots: The WG "Prognosis and decision making" of the GMDS (U. Mansmann) and the German BUGS User Group...

246. Discussant

Reinhard Vonthein

19/05/2026, 11:55

oral presentation